RYVLX
Price
$631.41
Change
+$3.95 (+0.63%)
Updated
Aug 7 closing price
Net Assets
1.19B
UUPIX
Price
$65.65
Change
+$1.90 (+2.98%)
Updated
Aug 7 closing price
Net Assets
8.43M
Interact to see
Advertisement

RYVLX vs UUPIX

Header iconRYVLX vs UUPIX Comparison
Open Charts RYVLX vs UUPIXBanner chart's image
Rydex NASDAQ-100® 2x Strategy A
Price$631.41
Change+$3.95 (+0.63%)
VolumeN/A
Net Assets1.19B
ProFunds UltraEmerging Markets I
Price$65.65
Change+$1.90 (+2.98%)
VolumeN/A
Net Assets8.43M
RYVLX vs UUPIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RYVLX vs. UUPIX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYVLX is a Buy and UUPIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RYVLX has more cash in the bank: 1.19B vs. UUPIX (8.44M). UUPIX pays higher dividends than RYVLX: UUPIX (1.22) vs RYVLX (0.00). RYVLX was incepted earlier than UUPIX: RYVLX (21 years) vs UUPIX (19 years). UUPIX (2.13) is less costly to investors than RYVLX (2.01). RYVLX is a more actively managed with annual turnover of: 383.00 vs. UUPIX (163.00). RYVLX has a lower initial minimum investment than UUPIX: RYVLX (2500) vs UUPIX (15000). UUPIX (45.00) and RYVLX (44.06) have marching annual gain over last year. RYVLX return over 5 years is better than : 125.18 vs. UUPIX (7.05).
RYVLXUUPIXRYVLX / UUPIX
Total Expense Ratio1.901.78107%
Annual Report Gross Expense Ratio2.012.1394%
Fund Existence21 years19 years-
Gain YTD13.96634.86440%
Front Load5%N/A-
Min. Initial Investment25001500017%
Min. Initial Investment IRAN/AN/A-
Net Assets1.19B8.44M14,072%
Annual Yield % from dividends0.001.22-
Returns for 1 year44.0645.0098%
Returns for 3 years117.1156.13209%
Returns for 5 years125.187.051,775%
Returns for 10 years667.2965.691,016%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AXSM104.321.06
+1.03%
Axsome Therapeutics
NRP104.290.13
+0.12%
Natural Resource Partners LP
CME280.95-0.40
-0.14%
CME Group
VOR2.07-0.02
-0.96%
Vor Biopharma
CODX0.25N/A
-1.75%
Co-Diagnostics